ArticleJournal of medical case reports2026
A case of giant juvenile fibroadenoma in an adolescent girl: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBreast masses in adolescents are predominantly benign and are most commonly associated with fibroepithelial tumors. These tumors represent a heterogeneous group of biphasic lesions, ranging from benign fibroadenomatoid changes to malignant phyllodes tumors. Differentiating between fibroadenomas and phyllodes tumors is clinically significant owing to their differing malignant potential and the consequent implications for treatment strategies. However, this distinction is often challenging, as the two entities share considerable overlap in both clinical presentation and imaging characteristics. For this reason, surgical excision of the mass followed by histopathological evaluation remains essential to ensure accurate diagnosis and to prevent overlooking malignant forms with metastatic potential. Giant juvenile fibroadenoma, a rare subtype of fibroadenoma, accounts for approximately 0.5-4% of cases in adolescents. Although histologically benign, its characteristic rapid growth frequently necessitates surgical intervention to alleviate symptoms and exclude malignancy. CASE PRESENTATION: We present the case of a 19‑year‑old female individual of Oromo ethnicity who developed a rapidly enlarging mass in the right breast. Surgical excision was performed, and histopathological evaluation confirmed the diagnosis of giant juvenile fibroadenoma. CLINICAL DISCUSSION: Giant juvenile fibroadenoma is an uncommon subtype of fibroadenoma, accounting for approximately 0.5-4% of cases in adolescents. It is defined by a tumor weight exceeding 500 g, a diameter greater than 5 cm, or a mass occupying more than four-fifths of the breast. Characteristically, it demonstrates rapid growth, leading to distortion and compression of the breast parenchyma. Although benign, its aggressive enlargement is particularly observed in children and adolescents. Diagnosis is primarily based on clinical evaluation and imaging studies. Clinically, the lesion presents as a well‑circumscribed, mobile mass with elastic consistency and clear contours, often resulting in breast deformity and aesthetic discomfort. Ultrasonography serves as the principal diagnostic modality, typically revealing a large, homogeneous, hypoechoic lesion. Given its rapid growth, surgical excision is the treatment of choice. Excision is warranted not only to prevent potential damage to the mammary gland but also to address cosmetic concerns and mitigate the negative impact on the patient's quality of life.
conclusionAlthough fibroadenomas, benign fibroepithelial lesions, represent the most common breast tumors in children and adolescents, histopathological confirmation remains indispensable to prevent misdiagnosis and to avoid overlooking malignant variants with metastatic potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.